Leaderboards/Infectious Diseases and Tuberculosis

Infectious Diseases and Tuberculosis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Poushali Chakraborty
Indian Institute of Chemical Biology
2
Radha Gopalaswamy
Madurai Kamaraj University
3
Elena Chesov
Nicolae Testemițanu State University of Medicine and Pharmacy
4
Munyaradzi Musvosvi
South African Tuberculosis Vaccine Initiative
5
Yoann Conan
Université de Tours
6
G.A. Wells
Africa Health Research Institute
7
Angharad Davis
University of Cape Town
8
Filipa Mota
University of Aveiro
9
Sahar Kazemzadeh
University of North Carolina at Chapel Hill
10
Qing Hao Miow
Michigan Cancer Research Consortium

Rising Stars Papers

1
Prospective Multi-Site Validation of AI to Detect Tuberculosis and Chest X-Ray Abnormalities
NEJM AI|2024
17 cit.
2
Synthesis of activated biochar incorporated PVA-silica composite and its application in the adsorption of polycyclic aromatic hydrocarbons from wastewater
Environmental Surfaces and Interfaces|2025
6 cit.
3
The power of resistance: mechanisms of antimicrobial resistance in <i>Mycobacterium tuberculosis</i> and its impact on tuberculosis management
Clinical Microbiology Reviews|2026
5 cit.
4
Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence?
Journal of Respiration|2025
2 cit.
5
Erratum for Gopalaswamy and Subbian, “The power of resistance: mechanisms of antimicrobial resistance in <i>Mycobacterium tuberculosis</i> and its impact on tuberculosis management”
Clinical Microbiology Reviews|2026
1 cit.
6
Réforme du 3e cycle et DES de Maladies Infectieuses et Tropicales : quel bilan? Une enquête transversale nationale.
Médecine et Maladies Infectieuses Formation|2025
0 cit.
7
P058 ANTI-INFLAMMATORY THERAPIES TO PREVENT CARDIOVASCULAR EVENTS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Canadian Journal of Cardiology|2025
0 cit.
8
Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis
ERJ Open Research|2025
0 cit.
9
Bacillus cereus as a Sustainable Bioremediation Agent: Mechanisms, Applications, and Future Prospects
Current Microbiology|2025
0 cit.
10
Pilot evaluation of a compact targeted next-generation sequencing with minimum biocontainment for rapid diagnosis of drug-resistant tuberculosis
Microbiology Spectrum|2026
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Anvesha Katti
The NorthCap University
2
Mikashmi Kohli
FIND
3
Marie-Pierre Revel
Hôpital Cochin
4
Radha Rajasingham
University of Minnesota System
5
Stephanie Griffith‐Richards
Stellenbosch University
6
Joseph Donovan
University of London
7
Michael Faloon
St. Joseph’s University Medical Center
8
Alex Sigal
Hebrew University of Jerusalem
9
Zohair Ahmed
International Islamic University, Islamabad
10
Azger Dusthackeer
National Institute of Research in Tuberculosis

Emerging Leaders Papers

1
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis
The Lancet Infectious Diseases|2022
602 cit.
2
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
Cell Host & Microbe|2022
241 cit.
3
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Nature Communications|2022
187 cit.
4
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Nature Communications|2023
97 cit.
5
Omicron infection enhances Delta antibody immunity in vaccinated persons
Nature|2022
89 cit.
6
Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults
New England Journal of Medicine|2023
82 cit.
7
Tuberculosis chest X-ray detection using CNN-based hybrid segmentation and classification approach
Biomedical Signal Processing and Control|2023
81 cit.
8
An efficient deep learning-based framework for tuberculosis detection using chest X-ray images
Tuberculosis|2022
67 cit.
9
A fine-grained deep learning model using embedded-CNN with BiLSTM for exploiting product sentiments
Alexandria Engineering Journal|2022
46 cit.
10
What level of D-dimers can safely exclude pulmonary embolism in COVID-19 patients presenting to the emergency department?
European Radiology|2022
26 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Stewart T. Cole
Institut Pasteur
2
Dick van Soolingen
Health Forecasting
3
JoAnne L. Flynn
University of Pittsburgh
4
Walter R. Wilson
Mayo Clinic in Arizona
5
Jeremy Farrar
World Health Organization
6
Robert J. Wilkinson
The Francis Crick Institute
7
Nalin Rastogi
Institut Pasteur de la Guadeloupe
8
David Alland
Rutgers, The State University of New Jersey
9
Andrew Vernon
The University of Texas at El Paso
10
Françoise Portaels
Instituut voor Tropische Geneeskunde

Current Senior Leaders Papers

1
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Nature|1998
7.9k cit.
2
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
The Journal of Experimental Medicine|1993
2.5k cit.
3
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
Clinical Infectious Diseases|2012
2.2k cit.
4
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Nature Medicine|2006
1.9k cit.
5
Massive gene decay in the leprosy bacillus
Nature|2001
1.8k cit.
6
A new evolutionary scenario for the <i>Mycobacterium tuberculosis</i> complex
Proceedings of the National Academy of Sciences|2002
1.6k cit.
7
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Clinical Infectious Diseases|2016
1.5k cit.
8
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
The Lancet|1993
1.3k cit.
9
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Nature|1992
1.3k cit.
10
Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of <i>Mycobacterium tuberculosis</i>
Journal of Clinical Microbiology|2006
1.3k cit.

Reagents for Infectious Diseases and Tuberculosis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 63

Histone H2A (D6O3A) Rabbit Monoclonal Antibody

#12349$161,351
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-ATP-Citrate Lyase (Ser455) (F4T8R) Rabbit Monoclonal Antibody

#97366$200,479
View Evidence →
Cell Signaling TechnologyEvidence 64

NAE1/APPBP1 (D9I4Z) Rabbit Monoclonal Antibody

#14321$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#69463$865
View Evidence →
Cell Signaling TechnologyEvidence 64

Oct-4A (C30A3) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)

#46570$458
View Evidence →
Cell Signaling TechnologyEvidence 64

CD74 (F6K1S) Rabbit Monoclonal Antibody

#70167$161,376
View Evidence →